Literature DB >> 8454349

Long-lived respiratory immune response to filamentous hemagglutinin following Bordetella pertussis infection.

D F Amsbaugh1, Z M Li, R D Shahin.   

Abstract

Systemic and mucosal B-cell-mediated immune responses to purified filamentous hemagglutinin (FHA) in mice were analyzed at different times following a single respiratory infection with Bordetella pertussis. Serum immunoglobulin G (IgG) anti-FHA and respiratory IgG and IgA anti-FHA antibodies were first detected at 3 weeks postinfection, reached high levels by 8 weeks postinfection, and remained at high levels 12 to 32 weeks postinfection. FHA-specific B lymphocytes isolated from the spleens or lungs of uninfected control mice or mice convalescing from B. pertussis respiratory infection were analyzed in limiting-dilution cultures. Analysis of culture supernatants for the production of antibodies to FHA revealed an increased frequency of FHA-specific B cells of both the IgG- and the IgA-secreting classes in the lungs and tracheas of aerosol-challenged mice; these levels remained high as late as 25 weeks postinfection, compared with those in uninfected controls. No corresponding increase in the frequency of FHA-specific B cells in the spleens of aerosol-infected mice was observed. This long-lasting response observed in cultured cells was radiation resistant, a result suggesting that this response was due to B cells already activated in vivo. Polymerase chain reaction analysis revealed low but detectable levels of B. pertussis chromosomal DNA in 75% of mice tested at 8 weeks postinfection and 37.5% of mice tested at 26 weeks postinfection, at which times high levels of anti-FHA antibody were detected. One explanation for these data may be that, in this animal model, a major adhesin of B. pertussis can persist and interact with components of the immune system to stimulate the production of specific antibody in the respiratory tract many weeks after a single B. pertussis infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8454349      PMCID: PMC281384          DOI: 10.1128/iai.61.4.1447-1452.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Dendritic cells support production of IgA and other non-IgM isotypes in clonal microculture.

Authors:  C E Schrader; A George; R L Kerlin; J J Cebra
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

2.  Cloning and sequencing of the structural gene for the porin protein of Bordetella pertussis.

Authors:  Z M Li; J H Hannah; S Stibitz; N Y Nguyen; C R Manclark; M J Brennan
Journal:  Mol Microbiol       Date:  1991-07       Impact factor: 3.501

3.  Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis.

Authors:  D Relman; E Tuomanen; S Falkow; D T Golenbock; K Saukkonen; S D Wright
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

4.  Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis.

Authors:  A M Delisse-Gathoye; C Locht; F Jacob; M Raaschou-Nielsen; I Heron; J L Ruelle; M de Wilde; T Cabezon
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

5.  Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection.

Authors:  K Bromberg; G Tannis; P Steiner
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

6.  Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.

Authors:  A Kimura; K T Mountzouros; D A Relman; S Falkow; J L Cowell
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

7.  Intracellular survival of virulent Bordetella pertussis in human polymorphonuclear leukocytes.

Authors:  L L Steed; M Setareh; R L Friedman
Journal:  J Leukoc Biol       Date:  1991-10       Impact factor: 4.962

8.  Murine lung immunity to a soluble antigen.

Authors:  D N Weissman; D E Bice; D W Siegel; M R Schuyler
Journal:  Am J Respir Cell Mol Biol       Date:  1990-04       Impact factor: 6.914

9.  Comparison of systemic and local immune responses after multiple pulmonary antigen exposures.

Authors:  M J Mason; N A Gillett; D E Bice
Journal:  Reg Immunol       Date:  1989 May-Jun

10.  Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis.

Authors:  R D Shahin; M J Brennan; Z M Li; B D Meade; C R Manclark
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  7 in total

1.  Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussis.

Authors:  N Mielcarek; I Nordström; F D Menozzi; C Locht; J Holmgren
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis.

Authors:  G Renauld-Mongénie; N Mielcarek; J Cornette; A M Schacht; A Capron; G Riveau; C Locht
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

3.  Genome rearrangements, deletions, and amplifications in the natural population of Bartonella henselae.

Authors:  Hillevi Lindroos; Olga Vinnere; Alex Mira; Dirk Repsilber; Kristina Näslund; Siv G E Andersson
Journal:  J Bacteriol       Date:  2006-08-25       Impact factor: 3.490

4.  Production of nontypeable Haemophilus influenzae HtrA by recombinant Bordetella pertussis with the use of filamentous hemagglutinin as a carrier.

Authors:  Sylvie Alonso; Eve Willery; Genevieve Renauld-Mongénie; Camille Locht
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

5.  Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen.

Authors:  N Mielcarek; J Cornette; A M Schacht; R J Pierce; C Locht; A Capron; G Riveau
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

6.  Virulence of Bordetella bronchiseptica: role of adenylate cyclase-hemolysin.

Authors:  P Gueirard; N Guiso
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

7.  Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidates.

Authors:  Si Ying Ho; Shi Qian Chua; Damian G W Foo; Camille Locht; Vincent T Chow; Chit Laa Poh; Sylvie Alonso
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.